Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026)
Bausch Health Companies (BHC) posted Amortization of Deferred Charges of $21.0 million for Q2 2026, up 50.0% sequentially from $14.0 million in Q1 2026, and down 48.78% YoY from $41.0 million in Q2 2025.
Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Amortization of Deferred Charges for 18 years, with the latest figure at $21.0 million in Q2 2026.
- Quarterly Amortization of Deferred Charges fell 48.78% year-over-year to $21.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $73.0 million (down 12.05% YoY) and the FY2025 annual result came in at $94.0 million, up 70.91% from the prior year.
- Amortization of Deferred Charges improved to $21.0 million in Q2 2026 per BHC's latest filing, from $14.0 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $50.0 million in Q2 2022 and troughed at $11.0 million in Q1 2023.
- A 5-year average of $19.3 million and a median of $14.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2022 and 2023: Amortization of Deferred Charges surged 316.67% in 2022, then tumbled 76.0% in 2023.
- Over 5 years, Amortization of Deferred Charges stood at $13.0 million in 2022, then rose by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then jumped by 57.14% to $22.0 million in 2025, then decreased by 4.55% to $21.0 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $21.0 million, $14.0 million, and $22.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.00 Mn |
| Jun 30, 2026 | 21.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 41.00 Mn |
| Jun 30, 2025 | 41.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |